ConductScience.org, home

Paper33403447

Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis.

Vinayagamani S and 5 others. Neuroradiology, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis. Papers, record 33403447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33403447

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis.
PubMed
Journal
Neuroradiology
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vinayagamani SSelvadasan
2Sabarish SSekar
3Nair SSSruthi S
4Tandon VVaibhav
5Kesavadas CChandrasekharan
6Thomas BBejoyhttps://orcid.org/0000-0003-0355-3375

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple SclerosisMajor topic
White MatterMajor topic
Brain
Gadolinium
Humans
Magnetic Resonance Imaging

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115523705High-field magnetic resonance imaging of brain iron: birth of a biomarker?NMR Biomed2004https://conductscience.org/library/papers/15523705PubMed
227256856
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
AJNR Am J Neuroradiol2016https://conductscience.org/library/papers/27256856PubMed
327365331Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.AJNR Am J Neuroradiol2016https://conductscience.org/library/papers/27365331PubMed
426800367Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).J Magn Reson Imaging2016https://conductscience.org/library/papers/26800367PubMed
515993137MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.J Neurol Sci2005https://conductscience.org/library/papers/15993137PubMed
622441196Association between pathological and MRI findings in multiple sclerosis.Lancet Neurol2012https://conductscience.org/library/papers/22441196PubMed
723315661Quantitative susceptibility mapping in multiple sclerosis.Radiology2013https://conductscience.org/library/papers/23315661PubMed
828522663The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.AJNR Am J Neuroradiol2017https://conductscience.org/library/papers/28522663PubMed
926471751Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.AJNR Am J Neuroradiol2016https://conductscience.org/library/papers/26471751PubMed
1019401576Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype.Radiology2009https://conductscience.org/library/papers/19401576PubMed
1124475808Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.Radiology2014https://conductscience.org/library/papers/24475808PubMed
1223925273Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease.Radiology2014https://conductscience.org/library/papers/23925273PubMed
1328705068Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.AJR Am J Roentgenol2017https://conductscience.org/library/papers/28705068PubMed
1419243035Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging.J Magn Reson Imaging2009https://conductscience.org/library/papers/19243035PubMed
1517893225Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.AJNR Am J Neuroradiol2007https://conductscience.org/library/papers/17893225PubMed
1630846435Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.AJNR Am J Neuroradiol2019https://conductscience.org/library/papers/30846435PubMed
1716677958Insights into brain microstructure from the T2 distribution.Magn Reson Imaging2006https://conductscience.org/library/papers/16677958PubMed
1829275977Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.Lancet Neurol2018https://conductscience.org/library/papers/29275977PubMed
1925848905Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.Radiology2015https://conductscience.org/library/papers/25848905PubMed
2023868451Iron and neurodegeneration in the multiple sclerosis brain.Ann Neurol2013https://conductscience.org/library/papers/23868451PubMed

See all 29 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41154182Quantitative MRI in Neuroimaging: A Review of Techniques, Biomarkers, and Emerging Clinical Applications.Brain Sci2025https://conductscience.org/library/papers/41154182PubMed
37658891Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group.Eur Radiol2024https://conductscience.org/library/papers/37658891PubMed
36562783Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.Eur Radiol2023https://conductscience.org/library/papers/36562783PubMed
36031875Susceptibility phase imaging of deep gray matter: Presenting the effects of slice orientation.Neuroradiol J2023https://conductscience.org/library/papers/36031875PubMed
35332015SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions.AJNR Am J Neuroradiol2022https://conductscience.org/library/papers/35332015PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33403447

GET https://conductscience.org/api/papers/v1/33403447/references?page=2